InformationClinical trials have complex eligibility criteria.
Always talk to your clinician about you’re interest in participating in a trial.
Learn why

Optimise reading forHealth ProfessionalsPatients

RecruitingLast updated:15 August 2023

Keyvibe-010: This study testing whether combination immunotherapy and targeted therapy (pembrolizumab + vibostolimab) is more effective than immunotherapy alone (pembrolizumab) at preventing cancer recurrence in people high-risk melanoma who have had their cancer removedA Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab With Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants With High-risk Stage II-IV Melanoma (KEYVIBE-010)

Clinical summary

Summary

Eligible participants will be randomly allocated to either the Experimental or Active Comparator Arms. In the Experimental Arm, participants will receive a co-formulation of 200mg pembrolizumab and 200mg vibostolimab administered as an intravenous infusion on Day 1 of each 3 week cycle for up to 17 cycles. In the Active Comparator Arm, participants will receive pembrolizumab alone (adults will receive 200mg and adolescent participants weigh less than 40kg will receive 2/mg/kg up to a maximum of 200mg) administered as an intravenous infusion on Day 1 of each 3 week cycle for up to 17 cycles.

Age

People12+

Phase

III

Trial Acronym

Keyvibe-010

More information

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Commercial Sponsor

Merck Sharp & Dohme LLC

Scientific Title

A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab With Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants With High-risk Stage II-IV Melanoma (KEYVIBE-010)

Eligibility

Inclusion

  • You have certain types of non-cancer medical conditions.
  • You have been diagnosed with a prior or secondary type of cancer.
  • You have had certain treatments, surgical procedures or drugs.

Exclusion

  • You have had a certain type of treatment or surgical procedure.
Message

Clinical trials have complex eligibility criteria.

Ask your doctor if this trial could be right for you.

Participating hospitals

Recruiting hospitals

InformationTell us if you find this trial availability is not accurate.Report inaccuracy

Get Support

Example

Cancer Connect

Speak with someone who has cancer clinical trial experience.

Learn more

Example

Cancer Council’s cancer nurses

If you need cancer information and practical support for yourself, a carer, family or friend, contact Cancer Council’s experienced cancer nurses on 131120.

Learn more

Example

Information for family, friends and carers

When you are considering a cancer clinical trial, it is a good idea to discuss it with your family, friends or carers.

Learn more